Raffa RB - Search Results

1

Opioid formulations designed to resist/deter abuse.

Raffa RB, Pergolizzi JV Jr. Raffa RB, et al. Drugs. 2010 Sep 10;70(13):1657-75. doi: 10.2165/11537940-000000000-00000. Drugs. 2010. PMID: 20731474 Review.

2

Non-analgesic effects of opioids: factors relevant to opioid abuse and abuse- deterrent formulations.

Pergolizzi JV, Raffa RB, Pergolizzi JS, Taylor R. Pergolizzi JV, et al. Among authors: raffa rb. Curr Pharm Des. 2012;18(37):6109-15. doi: 10.2174/138161212803582379. Curr Pharm Des. 2012. PMID: 22747546 Review.

3

Designing opioids that deter abuse.

Raffa RB, Pergolizzi JV Jr, Muñiz E, Taylor R Jr, Pergolizzi J. Raffa RB, et al. Pain Res Treat. 2012;2012:282981. doi: 10.1155/2012/282981. Epub 2012 Nov 8. Pain Res Treat. 2012. PMID: 23213510 Free PMC article.

4

Opioid-induced hyperalgesia: is it clinically relevant for the treatment of pain patients?

Raffa RB, Pergolizzi JV Jr. Raffa RB, et al. Pain Manag Nurs. 2013 Sep;14(3):e67-83. doi: 10.1016/j.pmn.2011.04.002. Epub 2011 Jun 25. Pain Manag Nurs. 2013. PMID: 23972873 Review.

5

Sequestered naltrexone in sustained release morphine or oxycodone - a way to inhibit illicit use?

Raffa RB, Taylor R Jr, Pergolizzi JV Jr. Raffa RB, et al. Expert Opin Drug Saf. 2014 Feb;13(2):181-90. doi: 10.1517/14740338.2013.841136. Epub 2013 Nov 11. Expert Opin Drug Saf. 2014. PMID: 24206269 Review.

6

Maximizing value in opioid utilization: Is oxycodone immediate release a good option for pain management?

Pergolizzi JV, Köknel Talu G, Zmponga G, Erdine S, Taylor R, Ayan B, Raffa RB. Pergolizzi JV, et al. Among authors: raffa rb. Agri. 2015;27(1):1-11. doi: 10.5505/agri.2015.79663. Agri. 2015. PMID: 25867868 Free article. Review.

7

Perspectives on Intravenous Oxycodone for Control of Postoperative Pain.

Pergolizzi JV Jr, Seow-Choen F, Wexner SD, Zampogna G, Raffa RB, Taylor R Jr. Pergolizzi JV Jr, et al. Among authors: raffa rb. Pain Pract. 2016 Sep;16(7):924-34. doi: 10.1111/papr.12345. Epub 2015 Sep 22. Pain Pract. 2016. PMID: 26393529 Review.

8

Abuse-deterrent opioids: an update on current approaches and considerations.

Pergolizzi JV Jr, Raffa RB, Taylor R Jr, Vacalis S. Pergolizzi JV Jr, et al. Among authors: raffa rb. Curr Med Res Opin. 2018 Apr;34(4):711-723. doi: 10.1080/03007995.2017.1419171. Epub 2018 Jan 10. Curr Med Res Opin. 2018. PMID: 29262730 Review.

9

What's holding back abuse-deterrent opioid formulations? Considering 12 U.S. stakeholders.

Pergolizzi JV Jr, Taylor R Jr, LeQuang JA, Raffa RB. Pergolizzi JV Jr, et al. Among authors: raffa rb. Expert Opin Drug Deliv. 2018 Jun;15(6):567-576. doi: 10.1080/17425247.2018.1473374. Epub 2018 May 16. Expert Opin Drug Deliv. 2018. PMID: 29739241 Review.

10

Oxycodone combinations for pain relief.

Raffa RB, Pergolizzi JV, Segarnick DJ, Tallarida RJ. Raffa RB, et al. Drugs Today (Barc). 2010 Jun;46(6):379-98. doi: 10.1358/dot.2010.46.6.1470106. Drugs Today (Barc). 2010. PMID: 20571607 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

365 results

Search Page

Filters